Master of Pharmaceutical Industry Practice Scholarship 2024 In Australia
Details For Master of Pharmaceutical Industry Practice Scholarship 2024 In Australia:
Master of Pharmaceutical Industry Practice International Student Scholarship at University of Queensland 2024 is offered for Masters degree in the field of Pharmaceutical Industry Practice.
The application must be submitted by January 15, 2024. The University of Queensland (UQ) is offering this scholarship, which has a value of only tuition costs up to a $10,000 reduction in fees. With the exception of Australia and New Zealand, all nationals are eligible for this Scholarship.
- Degree: Masters
- Provided by: University of Queensland (UQ)
- Deadline: 15 Jan 2024
- Scholarship value: Only tuition fees, up to AUD 10,000 fees reduction
- Location: Australia
About the Scholarship:
For overseas students who excel academically, the Master of Pharmaceutical Industry Practice Scholarship is a fantastic opportunity. A $5,000 to $10,000 tuition fee grant will be awarded to scholars. The selection committee will decide how much is ultimately given to the applicants that are selected.
More Scholarships:
ARES Fully Funded Scholarship Program in Belgium
UCLA Math Undergraduate Merit Scholarship In USA
Helmut Veith Stipend In Austria
Eligibility:
- Applicant must be an international student and don’t hold another scholarship.
- Candidates should have received an unconditional offer or have already confirmed their place in the Master of Pharmaceutical Industry Practice at UQ.
Documents required:
- CV/resume
- A reference letter from academic staff at your institution or from an employer (the academic reference letter should rank your academic performance against your peer group).
- Personal/motivational statement. This statement should be no more than 1,000 words and address the reasons for your interest in studying the Master of Pharmaceutical Industry Practice at UQ and your personal goals and ambitions.
Selection criteria:
- Academic excellence
- Personal qualities
APPLY
Share:
